Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
August 30, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Reports Second Quarter 2022 Financial Results
August 02, 2022 06:48 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for...
Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development
August 01, 2022 16:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
July 13, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus Biotechnology Reports First Quarter 2022 Financial Results
May 03, 2022 06:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for...
Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development
April 12, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
April 07, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus Biotechnology to Present at EuPA and AACR Meetings
April 04, 2022 08:00 ET
|
Nautilus Biotechnology Inc.
• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate Director Greg Kapp, Ph.D., to present poster at...
Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
March 31, 2022 16:05 ET
|
Nautilus Biotechnology Inc.
SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 24, 2022 06:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...